Elizabeth E. Reed

Companies

• Travere Therapeutics, Inc.General counsel May 5, 2025 to now¹
• Travere Therapeutics, Inc.SVP, GC & Corporate Secretary Jan 6, 2017 to Feb 12, 2025²
• Eiger BioPharmaceuticals, Inc.General counsel Jun 11, 2014 to Jan 5, 2015³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTravere Therapeutics, Inc. TVTX105,389 shares⁴$5.6M at $53.15Sep 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 15, 2026Sold 300 shares at $65.31 of Travere Therapeutics, Inc.⁴
• Sep 15, 2026Sold 1,400 shares at $63.69 of Travere Therapeutics, Inc.⁴
• Sep 15, 2026Sold 13,874 shares at $62.63 of Travere Therapeutics, Inc.⁴
• Sep 15, 2026Sold 21,926 shares at $62.03 of Travere Therapeutics, Inc.⁴
• Sep 15, 2026Exercised options 37,500 shares at $15.46 of Travere Therapeutics, Inc.⁴
• May 6, 2026Sold 2,076 shares at $43.95 of Travere Therapeutics, Inc.⁵
• May 5, 2026Sold 2,174 shares at $46.65 of Travere Therapeutics, Inc.⁵
• May 4, 2026Exercised options 4,250 shares of Travere Therapeutics, Inc.⁵
• May 4, 2026Sold 20,000 shares at $45.00 of Travere Therapeutics, Inc.⁵
• May 4, 2026Exercised options 20,000 shares at $17.96 of Travere Therapeutics, Inc.⁵
• Apr 15, 2026Sold 1,559 shares at $42.53 of Travere Therapeutics, Inc.⁶
• Apr 15, 2026Sold 5,226 shares at $41.62 of Travere Therapeutics, Inc.⁶
• Apr 14, 2026Sold 7,215 shares at $41.93 of Travere Therapeutics, Inc.⁶
• Apr 14, 2026Sold 37,500 shares at $41.07 of Travere Therapeutics, Inc.⁶
• Apr 14, 2026Exercised options 7,500 shares at $15.46 of Travere Therapeutics, Inc.⁶
• Apr 14, 2026Exercised options 20,000 shares at $17.96 of Travere Therapeutics, Inc.⁶
• Apr 14, 2026Exercised options 10,000 shares at $19.08 of Travere Therapeutics, Inc.⁶
• Apr 13, 2026Granted 14,000 shares of Travere Therapeutics, Inc.⁶
• Apr 1, 2026Sold 10,000 shares at $30.00 of Travere Therapeutics, Inc.⁷
• Apr 1, 2026Exercised options 10,000 shares at $15.46 of Travere Therapeutics, Inc.⁷
• Mar 16, 2026Sold 10,000 shares at $28.09 of Travere Therapeutics, Inc.⁸
• Mar 16, 2026Exercised options 10,000 shares at $19.08 of Travere Therapeutics, Inc.⁸
• Feb 17, 2026Sold 4,321 shares at $28.26 of Travere Therapeutics, Inc.⁹
• Feb 17, 2026Sold 5,679 shares at $27.50 of Travere Therapeutics, Inc.⁹
• Feb 17, 2026Exercised options 10,000 shares at $19.08 of Travere Therapeutics, Inc.⁹